Skip to main content

Revolution Medicines, Inc.

RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001628171

In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.

Other share classesRVMDW

13F holders, Q4 2021

Institutional positions in Revolution Medicines, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
117
+4 vs. Q3 2021
Shares held
73.3M
+1.03M (+1.4%) vs. Q3 2021
Total value
$1.85B
−$143.2M (−7.2%) vs. Q3 2021
New holders
19
40 more added
Sold out
15
29 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 117 institutions
Q1 2021: 128 institutionsQ2 2021: 130 institutionsQ3 2021: 114 institutionsQ4 2021: 117 institutionsQ1 2022: 126 institutionsQ2 2022: 135 institutionsQ3 2022: 142 institutionsQ4 2022: 135 institutionsQ1 2023: 152 institutionsQ2 2023: 139 institutionsQ3 2023: 168 institutionsQ4 2023: 184 institutionsQ1 2024: 210 institutionsQ2 2024: 223 institutionsQ3 2024: 255 institutionsQ4 2024: 281 institutionsQ1 2025: 284 institutionsQ2 2025: 308 institutionsQ3 2025: 323 institutionsQ4 2025: 387 institutionsQ1 2026: 514 institutionsQ2 2026: 693 institutions
Value heldQ4 2021: $1.85B
Q1 2021: $3.05BQ2 2021: $2.23BQ3 2021: $1.99BQ4 2021: $1.85BQ1 2022: $1.89BQ2 2022: $1.49BQ3 2022: $1.74BQ4 2022: $2.10BQ1 2023: $2.34BQ2 2023: $2.99BQ3 2023: $3.11BQ4 2023: $4.59BQ1 2024: $5.18BQ2 2024: $6.54BQ3 2024: $7.74BQ4 2024: $8.45BQ1 2025: $6.83BQ2 2025: $7.02BQ3 2025: $8.96BQ4 2025: $15.9BQ1 2026: $19.1BQ2 2026: $40.1B
Institutions holding RVMD and their total value by quarter
QuarterHoldersValue
Q2 2026693$40.1B
Q1 2026514$19.1B
Q4 2025387$15.9B
Q3 2025323$8.96B
Q2 2025308$7.02B
Q1 2025284$6.83B
Q4 2024281$8.45B
Q3 2024255$7.74B
Q2 2024223$6.54B
Q1 2024210$5.18B
Q4 2023184$4.59B
Q3 2023168$3.11B
Q2 2023139$2.99B
Q1 2023152$2.34B
Q4 2022135$2.10B
Q3 2022142$1.74B
Q2 2022135$1.49B
Q1 2022126$1.89B
Q4 2021117$1.85B
Q3 2021114$1.99B
Q2 2021130$2.23B
Q1 2021128$3.05B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q3 2021.

Institutions holding RVMD in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
JPMorgan Chase & Co1,281,701$32.3M0.00%−36,943−2.8%Reduced
TRV GP IV, LLC1,419,900$35.7M10.28%00.0%Unchanged
BVF Inc1,810,549$45.6M1.65%−674,500−27.1%Reduced
Casdin Capital, LLC2,370,000$59.7M1.68%−430,000−15.4%Reduced
Cormorant Asset Management, LP2,431,852$61.2M3.64%−712,848−22.7%Reduced
Farallon Capital Management, L.L.C.2,750,000$69.2M0.39%00.0%Unchanged
State Street Corp2,754,633$69.3M0.00%−54,539−1.9%Reduced
Woodline Partners LP2,930,038$73.7M1.08%+2,060,554+237.0%Added
Nextech Invest AG2,968,214$74.7M19.68%+2,968,214New
The Column Group LLC3,347,245$84.3M11.46%00.0%Unchanged
Bellevue Group AG3,470,162$87.3M0.90%+11,357+0.3%Added
Boxer Capital, LLC3,484,264$87.7M3.49%00.0%Unchanged
Wellington Management Group LLP4,510,895$113.5M0.02%−26,207−0.6%Reduced
BlackRock Inc.5,475,219$137.8M0.00%+369,181+7.2%Added
TRV GP III, LLC5,524,031$139.0M34.79%00.0%Unchanged
FMR LLC6,101,724$153.6M0.01%−1,696,160−21.8%Reduced
Vanguard Group Inc6,299,609$158.6M0.00%+59,411+1.0%Added
Commodore Capital LP0$00.00%−226,228−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−55,000−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−53,384−100.0%Sold out
Bailard, Inc.0$00.00%−41,500−100.0%Sold out
HighVista Strategies LLC0$00.00%−23,637−100.0%Sold out
Algert Global LLC0$00.00%−15,272−100.0%Sold out
Winton Group Ltd0$00.00%−10,350−100.0%Sold out
Belvedere Trading LLC0$00.00%−9,792−100.0%Sold out
Wilbanks Smith & Thomas Asset Management LLC0$00.00%−9,041−100.0%Sold out
Victory Capital Management Inc0$00.00%−7,396−100.0%Sold out
Penserra Capital Management LLC0$00.00%−1,690−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,070−100.0%Sold out
Allworth Financial LP0$00.00%−100−100.0%Sold out
Signaturefd, LLC0$00.00%−26−100.0%Sold out
Harbour Investments, Inc.0$00.00%−1−100.0%Sold out
First Mercantile Trust Co––––Not filed